somes

Control of ADB-CHMINACA psychoactive substance

Summary

The European Parliament approves control measures for the new psychoactive substance ADB-CHMINACA.
10 22.05.2018
Other
health
criminal law
public safety
european union

Key points

  • Approval of control measures for a specific new psychoactive substance.
  • Identification and regulation of the chemical compound known as ADB-CHMINACA.
  • Application of EU-wide risk assessment and information exchange protocols for drug control.
  • Requirement for the Council to notify Parliament if it intends to deviate from or substantially amend the approved text.
Documents (PDFs)
REPORT on the draft Council implementing decision on subjecting the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) to control measures Subjecting the new psychoactive substance ADB-CHMINACA to control measures *
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.